IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents

<< Previous Issue

Dec 2012 (Vol: 2012, Issue: 12)

Next Issue >>

Download pdf of entire issue

Section: Joint Venture
Nestlé and Chi-Med Form Joint Venture to Develop Drugs Based on Traditional Chinese Medicine Published: 15 Dec-2012
By: Heather Cartwright
Abstract Fulltext:
Section: Licensing
Teva Licenses Xenon Pharmaceuticals’ Pain Drug XEN402 as Part of New Strategic Plan Published: 31 Dec-2012
By: Heather Cartwright
Abstract Fulltext:
Isis Pharmaceuticals Ends 2012 with an Antisense Cancer Alliance with AstraZeneca Published: 31 Dec-2012
By: Heather Cartwright
Abstract Fulltext:
Section: Mergers & Acquisitions
Wright Medical Bets on BioMimetic Therapeutics with Merger Agreement Published: 1 Dec-2012
By: Heather Cartwright
Abstract Fulltext:
Reckitt Benckiser Ventures into Vitamins, Minerals and Supplements Market with Schiff Nutrition Purchase Published: 7 Dec-2012
By: Heather Cartwright
Abstract Fulltext:
BASF Aims for Top Spot in Omega-3 API Market with Pronova BioPharma Acquisition Published: 10 Dec-2012
By: Heather Cartwright
Abstract Fulltext:
Smith & Nephew Moves into Fast-Growing Bioactive Wound Care Segment with Healthpoint Biotherapeutics Acquisition Published: 13 Dec-2012
By: Heather Cartwright
Abstract Fulltext:
Amgen Makes Long-Term Investment in Targeted Therapies with deCODE Genetics Purchase Published: 24 Dec-2012
By: Heather Cartwright
Abstract Fulltext:
Section: Research & Development
Selecta Biosciences Partners with Sanofi to Develop Antigen-Specific Immunotherapies for Allergies Published: 11 Dec-2012
By: Heather Cartwright
Abstract Fulltext:
Biogen Idec Signs Third Antisense Deal of 2012 with Isis Pharmaceuticals Published: 31 Dec-2012
By: Heather Cartwright
Abstract Fulltext:

Login Problems

Please enter your username or email address and we will email you your login details.